Morpholine-4-carboximidamide hydrochloride, 95.0%, 250mg

Ethyl 3-(4-chlorophenyl)acrylate, 95.0%, 25g

Copper(II) sulphate, min. 99%, pa, anhydrous, 2.5 kg, plastic packaging.

2-Tridecenoic Acid>80.0%(GC)5g

Methyl 3-chloro-4-hydroxybenzoate, 98.0%, 1g

2-Bromo-4'-hydroxyacetophenone>98.0%(HPLC)(T)5g

Centrifuge glasses thick-walled with conical bottom, 30° angle, 100 Piece(s)

(S)-3-(1-(tert-Butoxycarbonyl)-1H-imidazol-4-yl)-2-((tert-butoxycarbonyl)amino)propanoic acid, 95.0%, 25g

rac-(1S,5R)-9-methyl-3,9-diazabicyclo[3.3.2]decane dihydrochloride, 95.0%, 1g

ethyl 6-(decyloxy)-7-ethoxy-4-oxo-1,4-dihydroquinoline-3-carboxylate, 98%, 5g

ALLYL 2,7-DIAZASPIRO[3.5]NONANE-2-CARBOXYLATE HCL, 95.0%, 1g

Ethyl 1,2,3,4-tetrahydroquinoline-2-carboxylate, 95.0%, 1g

Toremifene Citrate>98.0%(HPLC)(T)1g